| Detailed information |
|---|
| CancerLivER ID | 2529 |
| Biomarker | HDAC2, PSMA7, PSMD1 |
| Biomarker Name/Symbol (given in Publication) | HDAC2, PSMA7, PSMD1 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential as a diagnostic marker and upregulated in HCC than non-tumorous tissue; but not validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC than non-tumorous tissue |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 15756260 |
| Type of Biomarker | Diagnostic |
| Pathway | SMAD Signaling Network and Signaling by NOTCH1, Beta-Adrenergic Signaling and Metabolism of proteins, |
| Cohort | Paired HCC and non-tumorous tissues from 16 HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2005 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |